CBD

/CBD

Awaiting Word on Rescheduling, the Market Watches Epidiolex

Pending word at any time, the United States Drug Enforcement Administration (DEA) is expected to reschedule Epidiolex, a CBD-based drug derived from cannabis. An announcement was due on Sept. 23, but by press time remained forthcoming. Manufactured by the London-based [...]

Despite Bumps, CBD Market Growing Toward Convenience Store Shelves

The potential both practical and profitable for cannabidiol (CBD) has been gaining an increasing amount of national attention. From alleviating intractable seizures to soothing anxiety, CBD’s health benefits have (anecdotally) become well known, which has translated to millions of dollars’ [...]

Charlotte’s Web Holdings (CNSX: CWEB) Quietly Raises $100 Million in IPO

It has been a busy, yet quiet week for the hemp-based CBD oil producer Charlotte’s Web Holdings, Inc. On August 30, 2018, the company reported the successful closing of its previously announced initial public offering (IPO), as well as a secondary [...]